We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WKC icon
276
World Kinect Corp
WKC
$2.06B
$15.6M 0.07%
505,748
-1,773
-0.3% -$49.1K
POR icon
277
Portland General Electric
POR
$5.92B
$15.6M 0.07%
325,945
+2,371
+0.7% +$111K
FDX icon
278
FedEx
FDX
$74B
$15.6M 0.07%
56,847
+2,064
+4% +$599K
DGX icon
279
Quest Diagnostics
DGX
$26B
$15.5M 0.07%
100,152
-1,673
-2% -$250K
YETI icon
280
Yeti Holdings
YETI
$3.93B
$15.4M 0.07%
376,452
-3,331
-0.9% -$131K
CTVA icon
281
Corteva
CTVA
$59.5B
$15.2M 0.07%
258,496
-2,884
-1% -$157K
TTMI icon
282
TTM Technologies
TTMI
$11.3B
$15.1M 0.07%
827,499
-11,505
-1% -$222K
BIIB icon
283
Biogen
BIIB
$30.4B
$15M 0.07%
77,301
+66,583
+621% +$13.9M
AZN icon
284
AstraZeneca
AZN
$267B
$14.9M 0.07%
95,566
+3,404
+4% +$549K
BYD icon
285
Boyd Gaming
BYD
$6.78B
$14.7M 0.07%
226,710
-3,048
-1% -$180K
ALKS icon
286
Alkermes
ALKS
$8.42B
$14.5M 0.07%
518,577
-5,537
-1% -$148K
RF icon
287
Regions Financial
RF
$26.7B
$14.5M 0.07%
620,467
+17,753
+3% +$388K
ENR icon
288
Energizer
ENR
$1.5B
$14.4M 0.07%
453,379
-4,763
-1% -$143K
QQQ icon
289
Invesco QQQ Trust
QQQ
$445B
$14.4M 0.07%
29,459
+3,553
+14% +$1.68M
LZB icon
290
La-Z-Boy
LZB
$1.65B
$14.4M 0.07%
334,289
-4,116
-1% -$169K
DHR icon
291
Danaher
DHR
$140B
$14.3M 0.07%
51,553
+142
+0.3% +$37.6K
EVH icon
292
Evolent Health
EVH
$421M
$14.2M 0.07%
503,823
-112
-0% -$2.89K
BKH icon
293
Black Hills Corp
BKH
$5.69B
$14.2M 0.07%
232,207
-4,570
-2% -$266K
CERT icon
294
Certara
CERT
$1.23B
$14.1M 0.07%
1,206,069
+530,598
+79% +$7M
HIG icon
295
Hartford Financial Services
HIG
$39.3B
$14.1M 0.07%
119,831
-1,910
-2% -$209K
AMT icon
296
American Tower
AMT
$79.9B
$14.1M 0.07%
60,560
-86,579
-59% -$19.2M
BERY
297
DELISTED
Berry Global Group, Inc.
BERY
$14M 0.07%
223,786
+11,246
+5% +$668K
NXST icon
298
Nexstar Media Group
NXST
$5.92B
$13.9M 0.07%
84,055
-1,261
-1% -$213K
DOX icon
299
Amdocs
DOX
$5.83B
$13.8M 0.07%
157,780
+24,442
+18% +$2.06M
NJR icon
300
New Jersey Resources
NJR
$6.04B
$13.8M 0.07%
291,456
-3,897
-1% -$178K
10 11
12
13 14

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.